Literature DB >> 11446565

Bone disease after liver transplantation: a long-term prospective study of bone mass changes, hormonal status and histomorphometric characteristics.

A Monegal1, M Navasa, N Guañabens, P Peris, F Pons, M J Martinez de Osaba, J Ordi, A Rimola, J Rodés, J Muñoz-Gómez.   

Abstract

After liver transplantation there is a high incidence of fractures, with important rates of bone loss during the first months. However, the long-term evolution of bone mass and metabolism parameters have been scarcely studied. In order to determine the incidence and risk factors involved in the development of skeletal fractures and to analyze the long-term evolution of bone mass, bone turnover and hormonal status after liver transplantation, a 3-year prospective study was performed in 45 patients following liver transplantation. Serum osteocalcin, parathyroid hormone (PTH), 25-hydroxyvitamin D (25-OH D) and testosterone levels (men), and bone mass at the lumbar spine and femur were measured before and sequentially at different time points during 3 years. Spinal X-rays were obtained during the first year. Histomorphometric analysis of bone biopsies obtained in 24 patients within the first 12 hours after surgery and 6 months after transplantation was performed. Fifteen patients (33%) developed fractures after liver transplantation, and pre-transplant risk factors for fractures were age and low bone mass (odd's ratio for osteoporosis, 95% confidence interval: 5.69, 1.32-24.53). Serum PTH, osteocalcin, 25-OH D, testosterone and creatinine levels increased after transplantation. Moreover, PTH correlated with creatinine and osteocalcin values. Bone mass decreased during the first 6 months and reached baseline values at the lumbar spine the second year, with posterior significant recovery at the femoral neck. Long term evolution of femoral neck BMD correlated with PTH levels. Six months after transplantation bone histomorphometric data showed an increase in bone formation parameters. After liver transplantation there is a high incidence of fractures, specially in elderly patients and those with osteoporosis. Bone mass decreased in the short-term period and improved, initially at the lumbar spine and later at the femur, according to histomorphometric evidences of an increase in bone formation. The increase in creatinine values induces a secondary hyperparathyroidism that influences the changes in femoral bone mass. Treatment of osteoporosis shortly after liver transplantation may be important in the prevention of bone fractures, particularly in patients with low bone mass.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11446565     DOI: 10.1007/s001980170094

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  31 in total

Review 1.  Osteoporosis after transplantation.

Authors:  Carolina A Moreira Kulak; Victoria Z Cochenski Borba; Jaime Kulak; Melani Ribeiro Custódio
Journal:  Curr Osteoporos Rep       Date:  2012-03       Impact factor: 5.096

Review 2.  Osteoporosis across chronic liver disease.

Authors:  M Guarino; I Loperto; S Camera; V Cossiga; C Di Somma; A Colao; N Caporaso; F Morisco
Journal:  Osteoporos Int       Date:  2016-02-04       Impact factor: 4.507

Review 3.  Hepatic osteodystrophy.

Authors:  Angelo Gatta; Alberto Verardo; Marco Di Pascoli; Sandro Giannini; Massimo Bolognesi
Journal:  Clin Cases Miner Bone Metab       Date:  2014-09

Review 4.  Vitamin D in organ transplantation.

Authors:  E M Stein; E Shane
Journal:  Osteoporos Int       Date:  2011-01-05       Impact factor: 4.507

5.  Factors associated with 1,25-dihydroxyvitamin D3 concentrations in liver transplant recipients: a prospective observational longitudinal study.

Authors:  Agnieszka Prytuła; Johan Vande Walle; Hans Van Vlierberghe; Jean-Marc Kaufman; Tom Fiers; Jo Dehoorne; Ann Raes
Journal:  Endocrine       Date:  2015-10-03       Impact factor: 3.633

6.  Zoledronic acid versus alendronate for the prevention of bone loss after heart or liver transplantation.

Authors:  Elizabeth Shane; Adi Cohen; Emily M Stein; Donald J McMahon; Chiyuan Zhang; Polly Young; Kavita Pandit; Ronald B Staron; Elizabeth C Verna; Robert Brown; Susan Restaino; Donna Mancini
Journal:  J Clin Endocrinol Metab       Date:  2012-09-28       Impact factor: 5.958

Review 7.  Male hypogonadism in cirrhosis and after liver transplantation.

Authors:  C Foresta; M Schipilliti; F A Ciarleglio; A Lenzi; D D'Amico
Journal:  J Endocrinol Invest       Date:  2008-05       Impact factor: 4.256

Review 8.  EASL Clinical Practice Guidelines on nutrition in chronic liver disease.

Authors: 
Journal:  J Hepatol       Date:  2018-08-23       Impact factor: 25.083

9.  Severe vitamin D deficiency among heart and liver transplant recipients.

Authors:  Emily M Stein; Adi Cohen; Matthew Freeby; Halley Rogers; Shannon Kokolus; Vanessa Scott; Donna Mancini; Susan Restaino; Robert Brown; Donald J McMahon; Elizabeth Shane
Journal:  Clin Transplant       Date:  2009-04-23       Impact factor: 2.863

10.  Suppressive effects of 1,4-dihydroxy-2-naphthoic acid administration on bone resorption.

Authors:  M Matsubara; E Yamachika; H Tsujigiwa; N Mizukawa; T Ueno; J Murakami; N Ishida; Y Kaneda; N Shirasu; S Takagi
Journal:  Osteoporos Int       Date:  2009-10-08       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.